Esophageal Baseline Impedance is Associated with Laryngopharyngeal Reflux and Treatment Response

Christopher M. Kurylo,Jacob Noel,Joel H. Blumin,Jonathan M. Bock
DOI: https://doi.org/10.1002/lary.31506
IF: 2.97
2024-05-24
The Laryngoscope
Abstract:Mean nocturnal baseline impedance (MNBI) is a value calculated on multichannel intraluminal impedance‐pH studies and provides a functional measure of the esophageal epithelial barrier. MNBI has been shown to help with the diagnosis, characterization, and management of patients with gastroesophageal reflux disease. We analyzed its utility in patients with laryngopharyngeal reflux (LPR) symptoms and found it to be predictive of LPR and responsiveness to antireflux treatment. Objective To evaluate the efficacy of distal esophageal mean nocturnal baseline impedance (MNBI), a general marker of esophageal mucosal barrier integrity, in predicting laryngopharyngeal reflux (LPR) and symptomatic response to acid reflux therapy. Methods This retrospective study analyzed 173 patients who presented with symptoms of laryngopharyngeal reflux and underwent 24‐h multichannel intraluminal impedance‐pH (MII‐pH) testing. Mean nocturnal baseline impedance values were calculated and assessed for their association and ability to predict LPR symptoms, MII‐pH results, treatment response, and other markers of LPR. Results Notably, 153 of the 173 patients were tested off acid suppression medication and included in statistical analysis. Based on the MII‐pH probe data, 108 (71%) patients had LPR, 8 (5%) had gastroesophageal reflux disease (GERD), and 37 (24%) were without pathologic reflux. Distal esophageal MNBI of LPR patients was significantly lower in LPR patients than patients with negative studies (1332 ± 94.8 vs. 2158 ± 173.5, p = 0.001). Among 118 patients who trialed antireflux therapy, a distal esophageal MNBI cutoff value of <1580 Ω was an independent predictor of treatment response (OR = 4.148 [1.877–9.189]). This value better predicted improvement with antireflux therapy for LPR than other objective MII‐pH probe data, which were not independent predictors of treatment response. Conclusion Distal esophageal MNBI values may have value in the diagnosis of LPR and potentially predict medication responsiveness in LPR patients. Level of Evidence 3 Laryngoscope, 2024
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?